{"id":"c78daa70-e469-5487-b4d7-0f2323171652","stable_key":"16c35a72-8162-5bb1-ae01-45331b8b42d0:moringa-prediabetes-glycemia","predicate":"improves_relative_to_placebo","statement":"In a 12-week double-blind trial in adults with prediabetes, 2.4 g/day Moringa dry leaf powder produced favorable fasting-glucose and HbA1c change scores relative to placebo.","claim_class":"observational","status":"source_derived_draft","evidence_grade":"ungraded","direction":"negative","is_public":true,"mechanism_event_id":"57251588-2a5b-5ace-abfd-f77106f2cab9","mechanism_event_label":"In a 12-week double-blind trial in adults with prediabetes, 2.4 g/day Moringa dry leaf powder produced favorable fasting-glucose and HbA1c change scores relative to placebo.","subject":{"id":"994f4608-74f6-55d1-b36b-f9284fce9960","slug":"moringa-leaf-powder","display_name":"Moringa dry leaf powder","entity_type_key":"botanical"},"object":{"id":"ca881519-cd22-5a3d-a32c-5f4f6728a2dc","slug":"human-prediabetes-fasting-glucose-hba1c","display_name":"Fasting glucose and HbA1c trajectory in adults with prediabetes","entity_type_key":"cellular_process"},"evidence_count":1,"mechanism_event":{"id":"57251588-2a5b-5ace-abfd-f77106f2cab9","stable_key":"16c35a72-8162-5bb1-ae01-45331b8b42d0:moringa-prediabetes-glycemia-event","event_type":"observed_relationship","label":"In a 12-week double-blind trial in adults with prediabetes, 2.4 g/day Moringa dry leaf powder produced favorable fasting-glucose and HbA1c change scores relative to placebo.","description":"In a 12-week double-blind trial in adults with prediabetes, 2.4 g/day Moringa dry leaf powder produced favorable fasting-glucose and HbA1c change scores relative to placebo.","status":"provisional","compartment":null,"participants":[{"entity":{"id":"994f4608-74f6-55d1-b36b-f9284fce9960","slug":"moringa-leaf-powder","display_name":"Moringa dry leaf powder","entity_type_key":"botanical"},"role":"subject","stoichiometry":null,"state_label":"","sequence_order":0,"notes":""},{"entity":{"id":"ca881519-cd22-5a3d-a32c-5f4f6728a2dc","slug":"human-prediabetes-fasting-glucose-hba1c","display_name":"Fasting glucose and HbA1c trajectory in adults with prediabetes","entity_type_key":"cellular_process"},"role":"target","stoichiometry":null,"state_label":"","sequence_order":1,"notes":""}]},"contexts":[{"dimension":"dose","value_text":"2.4 g/day dry leaf powder or placebo","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"duration","value_text":"12 weeks","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"evidence_access","value_text":"Primary PubMed abstract and indexed metadata reviewed. Full-text method details not stated here remain unresolved.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"evidence_scope","value_text":"literature_reviewed; model-specific source-derived curation","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"experimental_model","value_text":"Sixty-five randomized adults with prediabetes","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"limitations","value_text":"The modest trial reports relative change trajectories and does not identify the active constituent or establish diabetes treatment efficacy.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"nutrient_topic","value_text":"Moringa oleifera chapter; interacting nutrients, drugs, peptides and proteins retain their experimental settings.","comparator":null,"unit":null,"notes":"","entity":{"slug":"moringa","display_name":"Moringa oleifera","entity_type_key":"botanical"}},{"dimension":"organism","value_text":"Sixty-five randomized adults with prediabetes","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"plain_language","value_text":"In a 12-week double-blind trial in adults with prediabetes, 2.4 g/day Moringa dry leaf powder produced favorable fasting-glucose and HbA1c change scores relative to placebo.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"primary_references","value_text":"Moringa oleifera Leaf Supplementation as a Glycemic Control Strategy in Subjects with Prediabetes. (2021). https://pubmed.ncbi.nlm.nih.gov/35010932/ DOI: 10.3390/nu14010057","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"route","value_text":"Oral","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"tissue","value_text":"Fasting blood glucose and HbA1c","comparator":null,"unit":null,"notes":"","entity":null}],"evidence":[{"id":"65a2cdf4-f10b-58f6-b514-4d40c254a66c","evidence_kind":"source_excerpt","locator":"Lines 134-143","start_line":134,"end_line":143,"excerpt":"## moringa-prediabetes-glycemia\nIn a 12-week double-blind trial in adults with prediabetes, 2.4 g/day Moringa dry leaf powder produced favorable fasting-glucose and HbA1c change scores relative to placebo.\nModel/species: Sixty-five randomized adults with prediabetes\nTissue/system: Fasting blood glucose and HbA1c\nExposure: 2.4 g/day dry leaf powder or placebo\nRoute: Oral\nDuration: 12 weeks\nLimits: The modest trial reports relative change trajectories and does not identify the active constituent or establish diabetes treatment efficacy.\nPrimary reference: Moringa oleifera Leaf Supplementation as a Glycemic Control Strategy in Subjects with Prediabetes. (2021). https://pubmed.ncbi.nlm.nih.gov/35010932/ DOI: 10.3390/nu14010057\nAccess: Primary PubMed abstract and indexed metadata reviewed. Full-text method details not stated here remain unresolved.","model_system":"Sixty-five randomized adults with prediabetes","directness":"reported_statement","verification_status":"source_derived_draft","notes":"Exact original curation span with primary citation; not a publisher quotation.","relationship":"supports","weight":1.0,"link_notes":"","source":{"id":"2752e9b3-e4b9-55fe-be07-944204cca4b8","stable_key":"import-16c35a72-8162-5bb1-ae01-45331b8b42d0","title":"Moringa oleifera: mechanism of action and interactions (2026-09-20)","document_type":"imported_text","citation_label":"Original AI-assisted source-specific curation with primary-study citations, model, exposure, route, duration, negative findings and limitations preserved. Not publisher full text.","file_path":"","sha256":"c4146a85ed4997fa117a83862fcf605ffb74110cf9f9cac8c63d1f6b07b8a57c","revision_id":"399ef3a4-8939-5df0-9f90-71d41dd6bab8","review_status":"unverified_draft","notes":""}}],"relations":[],"conflicts":[],"corrections":[],"research":null}